Back

Integrating metabolomics and proteomics to identify novel drug targets for heart failure and atrial fibrillation

20 March 2024 (16:00 - 17:00)
Organised by: Logo
Seminar Presentation Part of: YIA Poster Session Drugs, Drug Targets HFA Premium Access HFA Winter Research Meeting on Translational Heart Failure 2024 Heart Failure Association of the ESC (HFA)

About the speaker

Photo
Ms Marion Van Vugt

Utrecht (Netherlands (The))

11 More presentations in this session

Presentation thumbnail
Iron deficiency in worsening heart failure is associated with a transcriptional profile of heme-sparing and reduced immune response processes
Doctor N. Grote Beverborg (Groningen, NL)
Abstract Slides
Presentation thumbnail
Modeling of LMNA H222P mutation-related cardiomyopathy using human induced pluripotent stem cells
Ms M. Seguret (Paris, FR)
Abstract Slides
Presentation thumbnail
Impact of Sphingosine Kinase 1 and S1P signaling in post-ischemic cardiomyocytes
Miss C. Vinciguerra (Naples, IT)
Abstract Slides
Presentation thumbnail
Hidden cardiotoxicity of tyrosine kinase inhibitors is associated with a distinct expression pattern of long non-coding RNAs
Mr R. Bernasconi (Basel, CH)
Abstract Slides
Presentation thumbnail
Large-scale manufacturing of GMP-grade Wharton's Jelly Mesenchymal Stromal Cell-derived Extracellular Vesicles: in vitro characterization and in vivo assessment for cardiac regeneration
Mr Y. Courageux (Badalona, ES)
Abstract Slides

Access the full session

Session thumbnail
YIA Poster Session

The Event

Event poster

HFA Winter Research Meeting on Translational Heart Failure 2024

20 March 2024 16:00 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources